Jim Cramer's 'Mad Money' Recap: A Monster of an August
at The Street - Tue Aug 26, 7:25PM CDT
After its best August in 14 years there's not much to fear in this market but much to embrace, Cramer says.
Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 6:00PM CDT
Alkermes (ALKS) submitted a New Drug Application for aripiprazole lauroxil in the U.S.
Celgene rose 2.4%
at Investor's Business Daily - Tue Aug 26, 5:45PM CDT
Celgene (CELG) rose 2.4% to 95.66 as an Deutsche Bank analyst said upcoming clinical trial data on a Crohn's disease drug could lift shares. The analyst also touted Gilead Sciences (GILD), which fell 1.1% but is still up 16% in Aug.
Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 5:44PM CDT
Kite Pharma, Inc. (KITE) announced the publication of positive results from an ongoing phase I-IIa study on KTE-C19 for aggressive non-Hodgkin's lymphoma.
Cardiome Pharma Signs Agreement with Eurolab for Brinavess - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 5:26PM CDT
Cardiome Pharma Corp. (CRME) announced that its subsidiary, Correvio International Srl, has entered into an agreement with Eurolab Especialidades Medicinales de Eurofar S.R.L. to sell and distribute Brinavess in Argentina.
Most active Nasdaq-traded stocks
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Final Glance: Biotechnology companies
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
Celgene, Gilead Lead Big Biotech Stock Movers
at Investor's Business Daily - Tue Aug 26, 4:55PM CDT
Big-cap biotechs moved in strong volume on the stock market today as Deutsche Bank added several to its short-term buy list, after Citi reported back from visits with medical experts. Celgene (CELG) hit a new high above 95 after Deutsche Bank analyst...
Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 4:20PM CDT
Regado Biosciences (RGDO) announced that it is permanently terminating the enrollment process for its phase III study on Revolixys Kit.
VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 4:00PM CDT
VIVUS, Inc. (VVUS) announced that it has acquired certain patents related to Topamax from Janssen Pharmaceuticals, Inc.
Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Tue Aug 26, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%. After the close, Amazon (AMZN) announced it was paying $970 million to buy Twitch, a live...
Midday Glance: Biotechnology companies
AP - Tue Aug 26, 12:31PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Should Gilead Sciences, inc. Fear This New Competitor Drug?
Todd Campbell, The Motley Fool - Motley Fool - Tue Aug 26, 10:41AM CDT
According to ViiV Healthcare -- GlaxoSmithKline , Pfizer , and Shionogi 's HIV drug consortium -- one in three Americans fails to take their HIV medication as prescribed. That means hundreds of thousands of patients aren't receiving the medicine...
Early Glance: Biotechnology companies
AP - Tue Aug 26, 10:12AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Stock Market News for August 26, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 9:10AM CDT
The S&P 500 closed at a record high and fellow benchmarks also ended in the green boosted by deal news
Gilead (GILD) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 8:54AM CDT
Gilead (GILD) Shares March Higher, Can It Continue?
Your September Biotech Back-to-School Calendar
at The Street - Tue Aug 26, 8:50AM CDT
The biotech sector hews close to an academic calendar and September marks the start of the busy, event-filled push into the end of the year.
Keryx Biopharmaceuticals (KERX) in Focus: Stock Adds 8.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 8:39AM CDT
Keryx Biopharmaceuticals Inc. (KERX) was a big mover last session, as its shares rose over 8% on the day.
TrovaGene (TROV) Jumps: Stock Rises 9.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 8:18AM CDT
TrovaGene, Inc. (TROV) was a big mover last session, as the company saw its shares rise over 9% on the day.